{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:37:48Z","timestamp":1760240268393},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bpg.2013.06.012","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T06:18:04Z","timestamp":1380608284000},"page":"513-530","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Liver in haematological disorders"],"prefix":"10.1016","volume":"27","author":[{"given":"Giulia","family":"Pieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Theocharidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ncpgasthep0143","article-title":"Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome","volume":"2","author":"Senzolo","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in\u00a0vitro in 20 patients with Budd-Chiari syndrome","volume":"103","author":"Valla","year":"1985","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.bpg.2013.06.012_bib5","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bpg.2013.06.012_bib6","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1478-3231.2012.02851.x","article-title":"Non conventional mutations associated with myeloproliferative disorders are absent in splanchnic venous thrombosis cases","volume":"32","author":"Jadli","year":"2012","journal-title":"Liver Int"},{"issue":"22","key":"10.1016\/j.bpg.2013.06.012_bib7","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","article-title":"JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","volume":"113","author":"Dentali","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bpg.2013.06.012_bib8","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.bpg.2013.06.012_bib10","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood-2010-11-319087","article-title":"The JAK2 46\/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis","volume":"117","author":"Smalberg","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bpg.2013.06.012_bib11","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2007-05-092502","article-title":"A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis","volume":"110","author":"Colaizzo","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0038-1655934","article-title":"Prevalence of mutated factor V ARG506 to GLN in Italians","volume":"77","author":"De","year":"1997","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ajcn\/77.5.1269","article-title":"Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation","volume":"77","author":"Bosy-Westphal","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.10149","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome","volume":"71","author":"Li","year":"2002","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2010.01551.x","article-title":"Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis","volume":"86","author":"Vaya","year":"2011","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00005792-199703000-00001","article-title":"Paroxysmal nocturnal hemoglobinuria as a molecular disease","volume":"76","author":"Rosse","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview","volume":"5","author":"Ziakas","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.bpg.2013.06.012_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200210270-00006","article-title":"Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders","volume":"74","author":"Melear","year":"2002","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres","volume":"44","author":"Mentha","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2004.02301.x","article-title":"Review article: portal vein thrombosis \u2013 new insights into aetiology and management","volume":"21","author":"Webster","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00004836-200404000-00013","article-title":"Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up","volume":"38","author":"Gurakan","year":"2004","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.bpg.2013.06.012_bib23","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bpg.2013.06.012_bib24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2011.04484.x","article-title":"Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms","volume":"9","author":"Hoekstra","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1160\/TH07-08-0526","article-title":"Inherited thrombophilic abnormalities and risk of portal vein thrombosis. A meta-analysis","volume":"99","author":"Dentali","year":"2008","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis","volume":"31","author":"Amitrano","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2011.09.010","article-title":"Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis","volume":"10","author":"Raffa","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction","volume":"41","author":"Primignani","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.bpg.2013.06.012_bib30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2011.12.034","article-title":"Portal vein thrombosis, cirrhosis, and liver transplantation","volume":"57","author":"Francoz","year":"2012","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2008.09.014","article-title":"The coagulation cascade in cirrhosis","volume":"13","author":"Monroe","year":"2009","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.bpg.2013.06.012_bib34","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"36","key":"10.1016\/j.bpg.2013.06.012_bib35","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3748\/wjg.v18.i36.5014","article-title":"What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective","volume":"18","author":"Ponziani","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0038-1655904","article-title":"Ongoing prothrombotic state in the portal circulation of cirrhotic patients","volume":"77","author":"Violi","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib37","first-page":"46","article-title":"Vascular liver disorders (II): portal vein thrombosis","volume":"67","author":"Hoekstra","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.bpg.2013.06.012_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","article-title":"Extrahepatic portal vein thrombosis: aetiology and determinants of survival","volume":"49","author":"Janssen","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib42","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2013.06.012_bib43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bpg.2013.06.012_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2013.06.012_bib45","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.transproceed.2012.09.050","article-title":"Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation","volume":"44","author":"D'Avola","year":"2012","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.bpg.2013.06.012_bib46","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib47","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2011.02.027","article-title":"Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe","volume":"55","author":"Senzolo","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/13651820701599033","article-title":"Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome","volume":"9","author":"Lendoire","year":"2007","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bpg.2013.06.012_bib50","article-title":"Portal vein thrombosis: a clinician-oriented and practical review","author":"Handa","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2012.02.054","article-title":"Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome","volume":"130","author":"Cliffe","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/lt.22351","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature","volume":"18","author":"Campos-Varela","year":"2012","journal-title":"Liver Transpl"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2013.06.012_bib53","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0168-8278(12)60004-X","article-title":"Management of hepatic vascular diseases","volume":"56","author":"Plessier","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy\u2013indications, adequacy, quality of specimens, and complications\u2013a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2013.06.012_bib55","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.bbmt.2012.10.023","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions","volume":"19","author":"Richardson","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"29","key":"10.1016\/j.bpg.2013.06.012_bib56","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3748\/wjg.v13.i29.3918","article-title":"Veno occlusive disease: update on clinical management","volume":"13","author":"Senzolo","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.bpg.2013.06.012_bib57","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-199610270-00009","article-title":"Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation","volume":"62","author":"Hagglund","year":"1996","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/lt.500020308","article-title":"Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver","volume":"2","author":"Rosen","year":"1996","journal-title":"Liver Transpl Surg"},{"issue":"5 Pt 1","key":"10.1016\/j.bpg.2013.06.012_bib59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib60","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jclinpath-2012-201139","article-title":"Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study","volume":"66","author":"Lo","year":"2013","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOT.0b013e3283465715","article-title":"Posttransplant lymphoproliferative disease following liver transplantation","volume":"16","author":"Kamdar","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PAP.0b013e3181916029","article-title":"Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist","volume":"16","author":"Ng","year":"2009","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib63","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003495-200666040-00003","article-title":"Post-transplant lymphoproliferative disease: association with induction therapy?","volume":"66","author":"Dharnidharka","year":"2006","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.bpg.2013.06.012_bib66","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/blood-2009-07-143545","article-title":"How I treat EBV lymphoproliferation","volume":"114","author":"Heslop","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2013.06.012_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib68","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","article-title":"Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports","volume":"22","author":"Evens","year":"2011","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.bpg.2013.06.012_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.bpg.2013.06.012_bib70","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2013.06.012_bib72","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","article-title":"Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients","volume":"57","author":"Mahale","year":"2012","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/jhep.2001.24114","article-title":"Sickle cell hepatopathy","volume":"33","author":"Banerjee","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01318115","article-title":"Pathological spectrum of liver diseases in sickle cell disease","volume":"31","author":"Omata","year":"1986","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.bpg.2013.06.012_bib75","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM199309163291204","article-title":"Marrow transplantation in patients with thalassemia responsive to iron chelation therapy","volume":"329","author":"Lucarelli","year":"1993","journal-title":"N Engl J Med"},{"issue":"9665","key":"10.1016\/j.bpg.2013.06.012_bib76","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","article-title":"Eculizumab for paroxysmal nocturnal haemoglobinuria","volume":"373","author":"Parker","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib77","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clinre.2012.11.001","article-title":"Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome)","volume":"37","author":"Korkmaz","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1872-034X.2009.00590.x","article-title":"Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: incidence and correlation with disease severity and survival","volume":"40","author":"Vassiliadis","year":"2010","journal-title":"Hepatol Res"},{"issue":"11","key":"10.1016\/j.bpg.2013.06.012_bib79","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00042737-199711000-00016","article-title":"Severe acute liver failure as the initial manifestation of haematological malignancy","volume":"9","author":"Souto","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.bpg.2013.06.012_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0344-0338(98)80068-X","article-title":"Incidence and pattern of liver involvement in haematological malignancies","volume":"194","author":"Walz-Mattmuller","year":"1998","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1995.tb01039.x","article-title":"Liver disease complicating bone marrow transplantation: a clinical audit","volume":"10","author":"Forbes","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/hep.1840170114","article-title":"Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma","volume":"17","author":"Hubscher","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib83","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(89)91706-X","article-title":"Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma","volume":"97","author":"Watterson","year":"1989","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2013.06.012_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2008-1040582","article-title":"Differential diagnosis of jaundice in lymphoma patients","volume":"7","author":"Birrer","year":"1987","journal-title":"Semin Liver Dis"},{"issue":"5\u20136","key":"10.1016\/j.bpg.2013.06.012_bib85","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/10428190109097665","article-title":"Primary hepatic lymphoma","volume":"40","author":"Chim","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840130512","article-title":"Non-Hodgkin's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients","volume":"13","author":"Scoazec","year":"1991","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"10.1016\/j.bpg.2013.06.012_bib87","first-page":"1163","article-title":"Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases","volume":"22","author":"Mican","year":"1995","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2013.06.012_bib88","first-page":"164","article-title":"Cholestatic liver disease in a 20-yr-old woman with histiocytosis X","volume":"83","author":"Iwai","year":"1988","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.1840210122","article-title":"Pediatric liver transplantation for Langerhans' cell histiocytosis","volume":"21","author":"Zandi","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2013.06.012_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy","volume":"6","author":"Gupta","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.bpg.2013.06.012_bib91","doi-asserted-by":"crossref","first-page":"508","DOI":"10.6002\/ect.2011.0204","article-title":"Liver transplant for adult hemophagocytic lymphohistiocytosis: case report and literature review","volume":"10","author":"Wright","year":"2012","journal-title":"Exp Clin Transpl"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181300125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181300125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T13:31:38Z","timestamp":1646659898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169181300125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S152169181300125X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.012","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver in haematological disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}